4-Hydroxy-N,N-diisopropyltryptammonium hydrofumarate
Maria Naeem, Andrew R Chadeayne, James A. Golen, David R. Manke
IUCrData June 1, 2025 DOI: 10.1107/s2414314625005644 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Key points | The solid-state structure of the hydrofumarate salt of 4-HO-DiPT is reported. |
Abstract
The solid-state structure of the hydrofumarate salt of the synthetic psychedelic 4-hydroxy-N,N-diisopropyltryptamine (4-HO-DiPT) is reported.
Citations in the library
Cites 19
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. New England Journal of Medicine November 3, 2022
- The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology August 1, 2015
- Psilocybin: from ancient magic to modern medicine The Journal of Antibiotics May 12, 2020
- A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression Frontiers in Psychiatry June 20, 2023
- Ancient Roots of Today's Emerging Renaissance in Psychedelic Medicine. Culture, Medicine, and Psychiatry December 1, 2022
and 14 more in the library